Why the study?
Is Triglyceride Glucose-Body Mass Index (TyG-BMI) a useful surrogate marker for identifying insulin resistance in nondiabetic individuals?
Is Triglyceride Glucose-Body Mass Index (TyG-BMI) a useful surrogate marker for identifying insulin resistance in nondiabetic individuals?
TyG-BMI can serve as a simple and clinically useful surrogate marker for the early identification of insulin resistance in nondiabetic individuals.
May support TyG-BMI for IR screening in nondiabetics; hypothesis-generating and requires prospective validation before practice change.
TyG-BMI is a simple, powerful, and clinically useful surrogate marker for early identification of IR.
No takes yet. Share an insight, caveat, or question.
Er et al. (2016) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:
More from PLoS ONE